ABCB1 and breast carcinoma: Here, we assessed that ABCB1 (P-glycoprotein) expression is strongly increased (log2FC = +5.301, about 40 times more) and it is known to be responsible for the eribulin resistance of many breast cancer cell lines, including the MDA-MB-231 used in this study [84,85,86].